高等学校化学学报

• 研究论文 • 上一篇    下一篇

含异噁唑片段的3-Methylcarbazole衍生物的设计、合成与抗菌活性

颜瑜1#,卢子聪2#,汪晴2,杨家强2   

  1. 1. 陆军军医大学第一附属医院(西南医院)康复科   2. 遵义医科大学药学院
  • 收稿日期:2026-04-14 修回日期:2026-05-30 网络首发:2026-06-04 发布日期:2026-06-04
  • 通讯作者: 杨家强 E-mail:yjqcn@126.com
  • 基金资助:
    贵州省科技计划项目(批准号:黔科合基础-ZK[2024]一般265)和国家级大学生创新创业训练计划项目(批准号:202510661273)资助

Design, Synthesis and Antibacterial Activities of 3-Methylcarbazole Derivatives Containing Isoxzole

YAN Yu1#, LU Zicong2#, WANG Qing2, YANG Jiaqiang2*   

  1. 1. Department of Rehabilitation, The First Affiliated Hospital(Southwest Hospital) of Army Medical University    2. School of Pharmacy, Zunyi Medical University
  • Received:2026-04-14 Revised:2026-05-30 Online First:2026-06-04 Published:2026-06-04
  • Supported by:
    Supported by the Guizhou Provincial Science and Technology Plan Project of China(No. Qiankehe Foundation ZK[2024]265) and the National College Students' Innovation and Entrepreneurship Training Program(No. 202510661273)

摘要: 为了获取抗菌候选化合物,以天然产物3-Methylcarbazole为苗头化合物,对其结构修饰及优化,先后设计合成了系列含异噁唑片段的3-Methylcarbazole衍生物,经1H NMR、13C NMR和元素分析确证其结构 . 结果显示,该类化合物对金黄色葡萄球菌(S. aureus)、表皮葡萄球菌(S. epidermidis)和耐甲氧西林金黄色葡萄球菌(MRSA)有较好的抑制作用,大部分衍生物的抗菌活性优于3-Methylcarbazole,尤以化合物3q最为突出,对三者的最小抑菌浓度(MIC)分别为0.5、1和2 μg·mL-1,抗S. aureus、S. epidermidis活性与对照药相当,抗MRSA活性远优于对照药;时间-杀菌曲线显示,化合物3q在4×MIC时,对S. aureus整个生长周期有快速杀菌作用;分子对接结果显示,化合物3q与靶蛋白GyrB有较好结合作用;同时,化合物3q对小鼠单核巨噬细胞无明显毒性. 异噁唑片段的引入,能提高3-Methylcarbazole的抗菌活性.

关键词: 3-Methylcarbazole衍生物, 结构修饰, 异噁唑, 合成, 抗菌活性

Abstract: In order to obtain antibacterial candidate compounds, natural product 3-methylcarbazole was used as a hit compound for structural modification and optimization. A series of 3-methylcarbazole derivatives containing isoxazole moieties were designed and synthesized, and their structures were confirmed by 1H NMR, 13C NMR and elemental analysis. Antibacterial activity tests showed that these compounds exhibited significant activity against S. aureus, S. epidermidis and methicillin-resistant S. aureus(MRSA), with most derivatives demonstrating superior antibacterial activity compared to 3-Methylcarbazole. Among them, compound 3q was the most prominent, with minimum inhibitory concentration(MIC) values of 0.5, 1 and 2 μg·mL-1 against the three strains, respectively. Its anti-S. aureus and anti-S. epidermidis activities were comparable to those of the control drugs, while its anti-MRSA effect was significantly superior to that of the control drugs. The time–kill curve showed that compound 3q exerted rapid bactericidal activity against S. aureus throughout its entire growth cycle at 4×MIC. Molecular docking results revealed that compound 3q exhibited favorable binding interactions with the target protein GyrB. Additionally, compound 3q showed no toxicity toward mouse mononuclear macrophages. The introduction of the isoxazole moiety can enhance the antibacterial activity of 3-methylcarbazole.

Key words: 3-Methylcarbazole derivatives, Structural modification, Isoxzole, Synthesis, Antibacterial activity

中图分类号: 

TrendMD: